|
|||||
|
|
Segmental stiff skin syndrome treated with secukinumab |
|
| Authors: | Alexa Gelinas MD Julie Powell MD Chantal Lapointe MSPT Jerome Coulombe MD |
| Affiliation: | 1. Faculty of Medecine, Universite de Montreal, Montreal, Canada;2. Division of Dermatology, Department of Pediatrics, CHU Sainte-Justine, Universite de Montreal, Montreal, Canada;3. Department of Pediatrics, CHU Sainte-Justine, Universite de Montreal, Montreal, Canada |
| Abstract: | Segmental stiff skin syndrome is a rare fibrosing scleroderma-like disorder characterized by progressive indurations of the skin leading to joint contractures, decreased mobility, and pain. Treatment options are limited; we report a patient that showed improvement with anti-IL17 biologic therapy. |
| Keywords: | biologic therapy IL-17 secukinumab segmental stiff skin syndrome |
